2011
DOI: 10.1136/bcr.10.2010.3429
|View full text |Cite
|
Sign up to set email alerts
|

Antiretroviral therapy and cardiovascular risk

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2015
2015
2018
2018

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(5 citation statements)
references
References 8 publications
(8 reference statements)
0
5
0
Order By: Relevance
“…Chronic immune activation, chronic inflammation, and progressive depletion of CD4+ T-cells experienced by PLHIV have been associated with the development of cardiovascular and metabolic comorbidities, including coronary plaque development, direct myocardial injury, left ventricular dysfunction, accelerated bone resorption, suppression of bone remodeling, and fractures (Carr, 2008; Hileman, Labbato, Storer, Tangpricha, & McComsey, 2014; Longenecker, Sullivan, & Baker, 2015; McComsey et al, 2010; Stein & Hsue, 2012). Furthermore, certain HIV treatments have been linked to dyslipidemia, insulin resistance, and bone loss, further increasing their risk for the development of comorbid conditions and acute cardiovascular and metabolic health complications (Anastos et al, 2007; Bedimo, Maalouf, Zhang, Drechsler, & Tebas, 2012; Brown et al, 2009; Brown & Qaqish, 2006; Calmy et al, 2013; Carr, 2008; Daria et al, 2011; Hileman et al, 2014; McComsey et al, 2010; Mueller et al, 2010; Mulligan et al, 2012; Ridha, Devitt, Boffito, & Boag, 2011). Compounding the risks is HIV and its treatment.…”
Section: Aging With Hivmentioning
confidence: 99%
See 1 more Smart Citation
“…Chronic immune activation, chronic inflammation, and progressive depletion of CD4+ T-cells experienced by PLHIV have been associated with the development of cardiovascular and metabolic comorbidities, including coronary plaque development, direct myocardial injury, left ventricular dysfunction, accelerated bone resorption, suppression of bone remodeling, and fractures (Carr, 2008; Hileman, Labbato, Storer, Tangpricha, & McComsey, 2014; Longenecker, Sullivan, & Baker, 2015; McComsey et al, 2010; Stein & Hsue, 2012). Furthermore, certain HIV treatments have been linked to dyslipidemia, insulin resistance, and bone loss, further increasing their risk for the development of comorbid conditions and acute cardiovascular and metabolic health complications (Anastos et al, 2007; Bedimo, Maalouf, Zhang, Drechsler, & Tebas, 2012; Brown et al, 2009; Brown & Qaqish, 2006; Calmy et al, 2013; Carr, 2008; Daria et al, 2011; Hileman et al, 2014; McComsey et al, 2010; Mueller et al, 2010; Mulligan et al, 2012; Ridha, Devitt, Boffito, & Boag, 2011). Compounding the risks is HIV and its treatment.…”
Section: Aging With Hivmentioning
confidence: 99%
“…Research on physical activity patterns in PLHIV is ongoing (Webel et al, 2015), but researchers have found that engaging in regular physical activity has the potential to reduce cardiovascular health events and symptom distress (Carr, 2008; Hileman et al, 2014; McComsey et al, 2010; Ridha et al, 2011) and to mitigate the impact of bone loss (Cotter & Mallon, 2012). Poverty is common in populations highly affected by HIV (CDC, 2015), and access to a public facility for exercise may not be an option.…”
Section: Promotion Of Self-management Behaviormentioning
confidence: 99%
“…Chronic immune activation, chronic inflammation, and progressive depletion of CD4+ T-cells experienced by PLHIV have been associated with the development of cardiovascular and metabolic comorbidities, including coronary plaque development, direct myocardial injury, left ventricular dysfunction, accelerated bone resorption, suppression of bone remodeling, and fractures (Carr, 2008;Hileman, Labbato, Storer, Tangpricha, & McComsey, 2014;Longenecker, Sullivan, & Baker, 2015;McComsey et al, 2010;Stein & Hsue, 2012). Furthermore, certain HIV treatments have been linked to dyslipidemia, insulin resistance, and bone loss, further increasing their risk for the development of comorbid conditions and acute cardiovascular and metabolic health complications (Anastos et al, 2007;Bedimo, Maalouf, Zhang, Drechsler, & Tebas, 2012;Brown et al, 2009;Brown & Qaqish, 2006;Calmy et al, 2013;Carr, 2008;Daria et al, 2011;Hileman et al, 2014;McComsey et al, 2010;Mueller et al, 2010;Mulligan et al, 2012;Ridha, Devitt, Boffito, & Boag, 2011). Compounding the risks is HIV and its treatment.…”
Section: Aging With Hivmentioning
confidence: 99%
“…Engagement in physical activity includes structured exercise and general (aka "free-life") physical activity that individuals perform in their everyday lives. Research on physical activity patterns in PLHIV is ongoing (Webel et al, 2015), but researchers have found that engaging in regular physical activity has the potential to reduce cardiovascular health events and symptom distress (Carr, 2008;Hileman et al, 2014;McComsey et al, 2010;Ridha et al, 2011) and to mitigate the impact of bone loss (Cotter & Mallon, 2012). Poverty is common in populations highly affected by HIV (CDC, 2015), and access to a public facility for exercise may not be an option.…”
Section: Physical Activitymentioning
confidence: 99%
“…ART promotes different metabolic disturbances, including hepatic and neurotoxicities, lipodystrophy syndrome, hyperlactatemia, hyperlipidemia, and insulin resistance [47,48] . The present study demonstrates that HHcy can be included on this list.…”
Section: Studymentioning
confidence: 99%